Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Topics Community

Article

Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic Innovation

10 Jun 2025

Abstract excerpt

Metabolic dysfunction-associated fatty liver disease (MAFLD) represents a global health burden, however, therapeutic advancements remain hindered by incomplete insights on mechanisms and suboptimal clinical interventions. This review focused on the transcription factors (TFs) associated with the gut-liver axis, emphasizing their roles as molecular interpreters of systemic crosstalk in MAFLD. We delineate how TF...

Source

Identifiers

PMID: 40564141
DOI: 10.3390/biomedicines13061422

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Orchestration of Gut–Liver-Associated Transcription Factors in MAFLD: From Cross-Organ Interactions to Therapeutic InnovationPMID 40564141Read ↗

Transcription factors, metabolic dysfunction-associated fatty liver disease, and therapeutic implicationsSemantic proximity Read ↗

A network-based approach reveals the dysregulated transcriptional regulation in non-alcoholic fatty liver diseaseSemantic proximity Read ↗

A network-based approach reveals the dysregulated transcriptional regulation in non-alcohol fatty liver diseaseSemantic proximity Read ↗

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in Metabolic-Associated Fatty Liver Disease and COVID-19 OutcomesSemantic proximity Read ↗

Modulatory Roles of AHR, FFAR2, FXR, and TGR5 Gene Expression in MAFLD and COVID-19 OutcomesSemantic proximity Read ↗

Unlocking therapeutic potential: exploring cross-talk among emerging nuclear receptors to combat metabolic dysfunction in steatotic liver diseaseSemantic proximity Read ↗

Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance Semantic proximity Read ↗

Transcriptional Regulation in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Nuclear factor interleukin 3 and metabolic dysfunction-associated fatty liver disease developmentSemantic proximity Read ↗

Metabolic Reprogramming of Liver FibrosisSemantic proximity Read ↗

Global molecular landscape of early MASLD progression in obesitySemantic proximity Read ↗

Hepatocyte TonEBP promotes metabolic stress-induced hepatic fibroinflammation involving transcriptional activation of ELR⁺ CXC chemokinesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.